Safety and Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Multiple Sclerosis

NCT05168384 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER_GOV

Sponsor class

Conditions

Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting
Multiple Sclerosis, Secondary Progressive

Interventions

COMBINATION_PRODUCT: Extracorporeal Photopheresis
COMBINATION_PRODUCT: MS standard of care

Sponsor

Abu Dhabi Stem Cells Center